Severe Covid patients cured in a day
Israel’s Bonus BioGroup (see here previously) tested its MesenCure MSC treatment on 10 severely ill, high risk Covid-19 patients at Haifa’s Rambam hospital. All ten improved sufficiently to be discharged just one day after treatment. MesenCure now advances to Phase 2 trials.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink